Does PONATINIB Cause Basal cell carcinoma? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Basal cell carcinoma have been filed in association with PONATINIB (Iclusig). This represents 0.1% of all adverse event reports for PONATINIB.
11
Reports of Basal cell carcinoma with PONATINIB
0.1%
of all PONATINIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Basal cell carcinoma From PONATINIB?
Of the 11 reports, 3 (27.3%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for PONATINIB.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which PONATINIB Alternatives Have Lower Basal cell carcinoma Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE